A Self-Paced Learning Activity - The Muscarinic System’s Role in Schizophrenia: Pathophysiology and Emerging Treatments
A Self-Paced Learning Activity - The Muscarinic System’s Role in Schizophrenia: Pathophysiology and Emerging Treatments is organized by Healthcare Made Practical (HMP) Global.
Release Date: March 20, 2023
Expiration Date: March 20, 2024.
Description:
This on-demand webcast is available with synchronized slides and video/audio.
To be eligible for credit, participants must complete the educational activity, complete the X-question post-test with a minimum score of 70%, and complete the activity evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Learning Objectives:
After participating in this activity, learners should be better able to:
• Assess barriers to optimal schizophrenia treatment, and outline strategies to overcome these barriers
• Evaluate the pharmacology, mechanisms of action, safety/efficacy data, and administration considerations associated with novel antipsychotic formulations targeting the muscarinic cholinergic system
• Describe how different MOAs can potentially be synergistic and when it may be beneficial to combine two MOAs to improve efficacy
• Implement strategies for patient-centered communication, including shared decision-making and motivational interviewing, to facilitate treatment selection and acceptance.
Additional details will be posted as soon as information is available.